Loading stock data…
$21.28-0.08 (-0.37%)
Artivion, Inc.
Artivion, Inc. in the Healthcare sector is trading at $21.28 with a market capitalization of $1.2B. Wall Street consensus targets $42.15 (8 analysts), implying a +98.1% move over the next 12 months. The stock is currently near its 52-week low of $19.16, remaining 30.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $125.76M↑ | $116.34M↑ | $115.99M↑ | $113.39M↑ | $112.97M |
| Gross Profit | $80.52M↑ | $75.45M↑ | $73.14M↓ | $74.39M↑ | $73.11M |
| Operating Income | -$8.36M↓ | $5.79M↓ | $7.18M↓ | $9.04M↑ | $8.38M |
| Net Income | -$13.51M↓ | $1.42M↓ | $2.43M↓ | $6.50M↑ | $1.34M |
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; C...